Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Véronique Mathieu

Showing results (31-40 of 105) with videos related to

Pageof 11
Sort By:
Translational Oncology|April 2, 2013
Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinasesMarina Bury, Anna Andolfi, Bernard Rogister, et al.
The Journal of Investigative Dermatology|May 15, 2007
Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma modelVéronique Mathieu, Marie Le Mercier, Nancy De Neve, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2014
Synthesis and biological evaluation of 9α- and 9β-hydroxyamino-parthenolides as novel anticancer agentsMohamed Moumou, Abderrahman El Bouakher, Hassan Allouchi, et al.
Molecules (Basel, Switzerland)|April 23, 2022
In Vitro Antioxidant and Anticancer Properties of Various <i>E. senegalensis</i> ExtractsSouleymane Fofana, Cédric Delporte, Rafaèle Calvo Esposito, et al.
Neoplasia (New York, N.Y.)|December 3, 2008
Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft modelVéronique Mathieu, Nancy De Nève, Marie Le Mercier, et al.
Cancers|March 27, 2019
Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of TemozolomideMargaux Colin, Cédric Delporte, Rekin's Janky, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2017
Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomasAude Ingels, Carina Dinhof, Abhishek D Garg, et al.
International Journal of Oncology|November 27, 2010
Evaluation of the anticancer activities of two fungal polycyclic ethanones, alternethanoxins A and B, and two of their derivativesMarina Bury, Biancavaleria Punzo, Alexander Berestetskiy, et al.
Cancers|November 9, 2013
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.
Toxicology and Applied Pharmacology|March 4, 2008
Evidence of galectin-1 involvement in glioma chemoresistanceMarie Le Mercier, Florence Lefranc, Tatjana Mijatovic, et al.
Pageof 11

Showing results (31-40 of 105) with videos related to

Sort By:
Pageof 11
Translational Oncology|April 2, 2013
Fusicoccin a, a phytotoxic carbotricyclic diterpene glucoside of fungal origin, reduces proliferation and invasion of glioblastoma cells by targeting multiple tyrosine kinasesMarina Bury, Anna Andolfi, Bernard Rogister, et al.
The Journal of Investigative Dermatology|May 15, 2007
Galectin-1 knockdown increases sensitivity to temozolomide in a B16F10 mouse metastatic melanoma modelVéronique Mathieu, Marie Le Mercier, Nancy De Neve, et al.
Bioorganic & Medicinal Chemistry Letters|July 8, 2014
Synthesis and biological evaluation of 9α- and 9β-hydroxyamino-parthenolides as novel anticancer agentsMohamed Moumou, Abderrahman El Bouakher, Hassan Allouchi, et al.
Molecules (Basel, Switzerland)|April 23, 2022
In Vitro Antioxidant and Anticancer Properties of Various <i>E. senegalensis</i> ExtractsSouleymane Fofana, Cédric Delporte, Rafaèle Calvo Esposito, et al.
Neoplasia (New York, N.Y.)|December 3, 2008
Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft modelVéronique Mathieu, Nancy De Nève, Marie Le Mercier, et al.
Cancers|March 27, 2019
Dysregulation of Macropinocytosis Processes in Glioblastomas May Be Exploited to Increase Intracellular Anti-Cancer Drug Levels: The Example of TemozolomideMargaux Colin, Cédric Delporte, Rekin's Janky, et al.
Cancer Chemotherapy and Pharmacology|April 9, 2017
Computed determination of the in vitro optimal chemocombinations of sphaeropsidin A with chemotherapeutic agents to combat melanomasAude Ingels, Carina Dinhof, Abhishek D Garg, et al.
International Journal of Oncology|November 27, 2010
Evaluation of the anticancer activities of two fungal polycyclic ethanones, alternethanoxins A and B, and two of their derivativesMarina Bury, Biancavaleria Punzo, Alexander Berestetskiy, et al.
Cancers|November 9, 2013
Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?Matthias van Woensel, Nathalie Wauthoz, Rémi Rosière, et al.
Toxicology and Applied Pharmacology|March 4, 2008
Evidence of galectin-1 involvement in glioma chemoresistanceMarie Le Mercier, Florence Lefranc, Tatjana Mijatovic, et al.
Pageof 11